Coldstream Capital Management Inc Enanta Pharmaceuticals Inc Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
A detailed history of Coldstream Capital Management Inc transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Coldstream Capital Management Inc holds 1,103 shares of ENTA stock, worth $6,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,103Holding current value
$6,000% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ENTA
# of Institutions
118Shares Held
20.2MCall Options Held
9.7KPut Options Held
12.4K-
Farallon Capital Management LLC San Francisco, CA2.12MShares$11.5 Million0.07% of portfolio
-
Krensavage Asset Management, LLC New York, NY2.12MShares$11.5 Million7.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.01MShares$10.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$10.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.22MShares$6.65 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $113M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...